
In a written response to a question in the Rajya Sabha, Union Science and Technology Minister Jitendra Singh said Cadila Healthcare Ltd's DNA-based vaccine candidate is in phase three clinical trial. It has also submitted the interim data for emergency use authorisation.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rkaTPA
via
IFTTT
0 comments:
Post a Comment